StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

Vycor Medical r&d expenses

Research and development expenses are spending on new products and technology.

Vycor Medical's R&D Expenses for the twelve months ending Dec 31, 2025 was $9.96K, down 35.0% year over year. For fiscal 2025 it was $9.96K, down 35.0% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $126.04K in fiscal 2012.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.96K-35.0%
FY2024Dec 31, 2024$15.33K-32.1%
FY2023Dec 31, 2023$22.56K+48.8%
FY2021Dec 31, 2021$15.16K–
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0-100.0%
FY2017Dec 31, 2017$3.02K-36.4%
FY2016Dec 31, 2016$4.74K-93.4%
FY2015Dec 31, 2015$71.51K+3.5%
FY2014Dec 31, 2014$69.11K+29.3%
FY2013Dec 31, 2013$53.45K-57.6%
FY2012Dec 31, 2012$126.04K+9.0%
FY2011Dec 31, 2011$115.67K+660.6%
FY2010Dec 31, 2010$15.21K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$4.20K+85.6%
Q1 FY2025Mar 31, 2025$5.76K+156.1%
Q4 FY2024Dec 31, 2024$6.64K-8.5%
Q3 FY2024Sep 30, 2024$6.43K-14.9%
Q2 FY2024Jun 30, 2024$2.26K-58.9%
Q4 FY2023Dec 31, 2023$2.25K-66.4%
Q3 FY2023Sep 30, 2023$7.25K+297.3%
Q2 FY2023Jun 30, 2023$7.55K+92.2%
Q1 FY2023Mar 31, 2023$5.51K+104.0%
Q4 FY2021Dec 31, 2021$6.71K+1044.2%
Q3 FY2021Sep 30, 2021$1.83K-56.1%
Q2 FY2021Jun 30, 2021$3.93K–
Q1 FY2021Mar 31, 2021$2.70K–
Q4 FY2016Dec 31, 2016$586–
Q3 FY2016Sep 30, 2016$4.15K–

More Vycor Medical figures

See a number that looks wrong?